No image
PGDx elio™ server
PGDx elio™ server (reconditioned 128C)
Details
Device typeCancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT): A collection of reagents and other associated materials intended for the qualitative and/or quantitative detection of mRNA expression and/or determination of the gene mutation status of multiple genes associated with cancer in a clinical specimen, using a nucleic acid technique (NAT). It is intended to be used in one or more of the following: select treatment options; predict or monitor the response to cancer therapy; risk assessment of cancer development, recurrence or metastasis; and/or for tumour profiling (e.g., cell-free DNA or circulating tumour DNA screening).
FDA categoryNext Generation Sequencing Based Tumor Profiling Test
Device ID00192721001456
Catalog numberB-01-40800
AvailabilityPrescription
MRI safetyLabeling does not contain MRI Safety Information